Canada
# |
Name |
EBITDA |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
---|---|---|---|---|---|---|---|
1 |
USD 2.60 M
|
Dec. 31, 2023 | USD 2.08 | 1.92% |
|
Canada |
|
2 |
USD -2.75 M
|
March 31, 2024 | USD 1.82 | -9.45% |
|
Canada |
|
3 |
USD -3.09 M
|
Dec. 31, 2023 | USD 2.66 | 14.16% |
|
Canada |
|
4 |
USD -3.24 M
|
Dec. 31, 2023 | USD 2.88 | 1.69% |
|
Canada |
|
5 |
USD -3.82 M
|
Dec. 31, 2023 | USD 2.82 | -2.42% |
|
Canada |
|
6 |
USD -6.13 M
|
Sept. 30, 2024 | USD 1.59 | -8.09% |
|
Canada |
|
7 |
USD -6.47 M
|
Dec. 31, 2023 | USD 1.25 | -0.34% |
|
Canada |
|
8 |
USD -7.26 M
|
Nov. 30, 2024 | USD 1.93 | -6.31% |
|
Canada |
|
9 |
USD -9.86 M
|
Nov. 30, 2023 | USD 1.71 | 4.46% |
|
Canada |
|
10 |
USD -10.40 M
|
Dec. 31, 2023 | USD 0.11 | 0.09% |
|
Canada |
|
11 |
USD -13.37 M
|
Dec. 31, 2023 | USD 2.12 | -1.09% |
|
Canada |
|
12 |
USD -13.78 M
|
March 31, 2024 | USD 0.91 | -2.78% |
|
Canada |
|
13 |
USD -21.04 M
|
Dec. 31, 2023 | USD 1.25 | -1.98% |
|
Canada |
|
14 |
USD -25.43 M
|
Dec. 31, 2023 | USD 0.82 | -3.10% |
|
Canada |
|
15 |
USD -26.73 M
|
Dec. 31, 2023 | USD 3.15 | -5.12% |
|
Canada |
|
16 |
USD -28.21 M
|
Dec. 31, 2023 | USD 3.02 | 1.15% |
|
Canada |
|
17 |
USD -28.45 M
|
Sept. 30, 2024 | USD 1.77 | 2.31% |
|
Canada |
|
18 |
USD -52.04 M
|
Oct. 31, 2024 | USD 7.58 | -5.96% |
|
Canada |
|
19 |
USD -56.84 M
|
Dec. 31, 2023 | USD 1.96 | -0.51% |
|
Canada |
|
20 |
USD -58.00 M
|
March 31, 2024 | USD 8.83 | -0.79% |
|
Canada |
|
21 |
USD -63.05 M
|
Dec. 31, 2023 | USD 7.55 | -2.83% |
|
Canada |
|
22 |
USD -92.57 M
|
Dec. 31, 2023 | USD 6.40 | -1.54% |
|
Canada |
|
23 |
USD -114.27 M
|
Dec. 31, 2023 | USD 1.27 | -3.05% |
|
Canada |
|
24 |
USD -120.70 M
|
Dec. 31, 2023 | USD 13.62 | -2.44% |
|
Canada |
|
25 |
USD -192.16 M
|
Dec. 31, 2023 | USD 2.77 | -7.67% |
|
Canada |
|
26 |
USD -210.51 M
|
Dec. 31, 2023 | USD 39.65 | 3.66% |
|
Canada |
The Biotechnology company in Canada with the highest EBITDA is BioRem Inc. (TSXV: BRM.V) at USD 2.60 M.
The Biotechnology company in Canada with the lowest EBITDA is Xenon Pharmaceuticals Inc. (NasdaqGM: XENE) at USD -210.51 M.
The top 10 Biotechnology companies in Canada by EBITDA are BioRem Inc., Psyence Biomedical Ltd., AgriFORCE Growing Systems Ltd., EcoSynthetix Inc., Sunshine Biopharma, Inc., Edesa Biotech, Inc., XORTX Therapeutics Inc., Lexaria Bioscience Corp., Theratechnologies Inc. and Ondine Biomedical Inc..
The bottom 10 Biotechnology companies in Canada by EBITDA are Xenon Pharmaceuticals Inc., AbCellera Biologics Inc., Zymeworks Inc., Repare Therapeutics Inc., Mind Medicine (MindMed) Inc., Aurinia Pharmaceuticals Inc., Cybin Inc., Milestone Pharmaceuticals Inc., enGene Holdings Inc. Common Stock and ESSA Pharma Inc..